C
오상헬스케어
036220KOSDAQ47.0 / 100
Reference Date: 2026-09-08
Financial Score20.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Declined 6.1% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Osang Healthcare is a company specializing in in vitro diagnostics (IVD), developing and selling biochemical, immunoassay, and molecular diagnostic products, including blood glucose meters, HbA1c devices, and cholesterol meters. It operates subsidiaries in the US and Brazil to expand its global market and is also pursuing new ventures in bio-healthcare.
Number of Employees
336people
Average Salary
57.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
29.38Industry Average 15.001.5Point
2.0x industry avg (risky)
PBR
0.34Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
1.10Industry Average 8.001.0Point
Well below industry avg
Debt Ratio
10.95Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼8.8% (2-year basis)
Operating Profit Growth Rate
0.5 / 3
Avg ▼3.8% (2-year basis)
ROE Trend
2.5 / 4
Avg ROE 14.8% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (11%, downtrend)
Current 6,640Won52-week high 16,57052-week low 5,390
1-month return2.0Point
1m -6.08% (slight drop)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral반기보고서 (2026.06)2026-08-14
- Neutral독립이사의선임ㆍ해임또는중도퇴임에관한신고2026-08-11